Morgan Stanley resumed coverage of UBS with an Equal Weight rating and CHF 21 price target. While the Credit Suisse deal is earnings accretive from 2026, 2023 and 2024 will be transition years, the analyst tells investors in a research note. The firm prefers a neutral rating when “taking execution uncertainty into account.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on UBS:
- UBS (NYSE:UBS) Streamlines Workforce After Forced Takeover of Credit Suisse
- UBS price target lowered to CHF 16 from CHF 16.50 at Barclays
- Credit Suisse’s lawsuit against SoftBank now in doubt, FT reports
- UBS (NYSE:UBS) Bears the Brunt of Credit Suisse’s Archegos Debacle
- UBS cutting ties with Odey Asset Management, FT reports
